Log In

Tonix Pharmaceuticals Holding Corp. (TNXP)

Retrospective Patient Analysis Shows Overlapping Symptoms Of Long COVID and Fibromyalgia

‌
Robert LeBoyerMedia Inquiries
Senior Life Sciences Analyst
September 23, 2022
Report ID: 25235
Get Report
Refer to the full report for the price target, fundamental analysis, and rating.
Get Report

Equity Research provided by Noble Capital Markets is available at no cost to Registered users of Channelchek.

Already Registered? Click the ‘Get Report’ button to login and view the research report.

Not a Member? Click ‘Join’ or ‘Get Report’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

‌
Tonix Pharmaceuticals Holding Corp.
Ticker
TNXP
Current Price
$0.1554 -2.87%
Market Cap
$13.1M
Price Target
Refer to Report
Volume
1.4M
52wk Range
$0.1202 - $3.3125
Fundamental Analysis:
Log in to view
Rating: Log in to view
Advanced Market Data
Related Research Reports
4/11/2024
‌
Increasing The Focus on Fibromyalgia
Increasing The Focus on Fibromyalgia (TNXP)
6 min read
12/21/2023
‌
Fibromyalgia Trial Meets All Endpoints
Fibromyalgia Trial Meets All Endpoints (TNXP)
2 min read
9/6/2023
‌
Long COVID Study Did Not Meet Primary Endpoint But Provides Important Data
Long COVID Study Did Not Meet Primary Endpoint But Provides Important Data (TNXP)
4 min read
8/14/2023
‌
Focus On CNS Transforms During 2Q23
Focus On CNS Transforms During 2Q23 (TNXP)
3 min read

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
Log In
© 2018-2024 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.
Log In